GLP-1 receptor agonists, medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), have changed the conversation around weight management. For many patients, they work. Appetite goes down. Weight follows. HbA1c improves. Patients who struggled for years with diet and exercise alone finally see the scale move.
But here is what I tell every patient who asks me about these medications: the medication is a tool, not a plan. And a tool used without a plan rarely builds anything that lasts.
What GLP-1 medications actually do
GLP-1, or glucagon-like peptide-1, is a hormone your gut naturally releases after eating. It signals your pancreas to produce insulin, tells your brain you are full, and slows down how fast your stomach empties. GLP-1 receptor agonists mimic this hormone and amplify its effects.
The result is a significant reduction in appetite. Many patients report that food simply becomes less interesting. Portions shrink naturally. Cravings quiet down. For people who have spent years fighting hunger, this relief is real and meaningful.
But here is the part that often gets left out of the conversation: GLP-1 medications reduce how much you eat. They do not control what you eat, how well your body uses nutrients, or what happens to your muscle mass as the weight comes off.
The muscle loss problem
When you lose weight quickly, you do not lose only fat. You lose muscle too. This is true for any method of weight loss, but it becomes a more serious concern with GLP-1 medications because the appetite suppression can be so strong that patients end up eating very little overall, not just fewer calories but far less protein.
Muscle is metabolically active tissue. It burns calories at rest. It supports mobility, balance, and function as you age. When you lose muscle, your resting metabolism drops, which makes it harder to maintain your weight once the medication is reduced or stopped. It is one of the key reasons people regain weight after discontinuing GLP-1 therapy.
In my clinic, I see this pattern regularly. A patient loses 10 to 15 kilograms over several months. Blood sugar improves. They feel lighter. But when we check body composition, a significant portion of what was lost was lean mass, not just adipose tissue. The scale went down, but the foundation for sustainable metabolic health did not get stronger.
What proper nutrition looks like on a GLP-1 medication
The goal is not to eat as little as possible. The goal is to eat strategically within a smaller appetite window, so that the calories you do consume are building the right things.
Prioritize protein at every meal
Protein is the most important macronutrient to protect during GLP-1 therapy. Most adults on a calorie-restricted program need at least 1.2 to 1.6 grams of protein per kilogram of body weight per day to preserve lean mass. When appetite is suppressed, this amount does not happen automatically.
For Filipino patients, this means being intentional about ulam. Fish, chicken, eggs, tofu, and legumes become the anchor of each meal, not an afterthought alongside a large serving of rice. A practical shift: eat the protein first. Fill half your plate with protein and vegetables before adding any rice.
Do not skip meals
Some patients on GLP-1 medications find they are simply not hungry and skip meals entirely. This feels fine in the short term but creates problems. Skipping meals reduces the total protein and micronutrient intake even further, increases the risk of muscle loss, and can contribute to fatigue and nutrient deficiency over time.
Smaller, more frequent meals are often better tolerated than three large ones. If a full meal feels like too much, a protein-rich snack, a boiled egg, a small serving of tinapa, a cup of soy milk, is better than nothing.
Do not neglect micronutrients
With significantly reduced food intake comes the real risk of micronutrient deficiency. Iron, calcium, vitamin B12, vitamin D, zinc, and folate are commonly affected. This is not a problem unique to GLP-1 medications but it is made worse when appetite suppression leads to a very restricted diet without medical supervision.
This is one reason I strongly recommend that patients on GLP-1 medications have their labs monitored regularly, not just blood sugar and weight, but a complete nutritional panel.
The habit window: why this period is an opportunity
Here is the part I find most important, and most underutilized.
GLP-1 medications quiet the noise. The constant food thoughts, the cravings, the emotional pull toward overeating, these become less loud. For many patients, it is the first time in years that they feel in control around food. That window is precious.
It is the ideal time to build the habits that will outlast the medication. Not because the medication is temporary by definition, but because the goal should never be permanent dependency on a drug. The goal is a version of yourself who eats well, moves regularly, and maintains a healthy weight because the habits are genuinely in place, not because the medication is suppressing your appetite.
The habits worth building during GLP-1 therapy:
- Eating slowly and stopping at 80 percent full. GLP-1 medications enhance satiety signals. Use this to practice recognizing when you are satisfied rather than stuffed.
- Restructuring your plate. Use the smaller appetite to practice proper portions rather than simply eating less of the same foods. Protein first, then vegetables, then a small amount of carbohydrate.
- Adding resistance exercise. This is non-negotiable for preserving muscle. Even 20 to 30 minutes of resistance training two to three times per week makes a meaningful difference in body composition outcomes.
- Addressing emotional eating patterns. For patients whose overeating was driven primarily by stress, boredom, or habit, the quieter appetite on GLP-1 medications gives you space to identify those triggers and build alternative responses. This is best done with guidance.
- Learning what your body actually needs. A structured nutrition program during this period teaches you what adequate protein looks like, what balanced meals feel like, and how to sustain energy without relying on large carbohydrate loads.
What happens when the medication is stopped
Studies consistently show that most patients regain a significant portion of lost weight within one to two years of stopping GLP-1 therapy. The hunger comes back. The food noise returns. Without a foundation of habits and a restructured relationship with food, the weight follows.
This is not a failure of willpower. It is biology. GLP-1 medications work in part by overriding the body's hunger signaling. When the medication stops, the signaling returns. If the habits were not built during the medication window, there is nothing to catch the rebound.
Patients who do best after discontinuing GLP-1 therapy are those who used the period actively: building muscle, adjusting their diet, learning what satiety actually feels like, and establishing eating patterns they can sustain independently.
The role of a physician-nutritionist in GLP-1 management
Managing a patient on GLP-1 therapy well requires looking at more than just the number on the scale. It requires monitoring body composition, not just weight. It requires adjusting protein targets as the patient's intake changes. It requires watching for micronutrient deficiencies before they become symptomatic. And it requires building a meal structure that works within the reduced appetite, not against it.
This is exactly where having a physician who is also a Registered Nutritionist-Dietitian changes the outcome. The medication decision and the nutritional strategy can be made together, in the same room, with the same understanding of where the patient is and where they need to go.
The medication can open a door. Nutrition and habit-building are what you build on the other side of it. Used together, thoughtfully, that combination produces results that are not just impressive on the scale but genuinely sustainable in your daily life.
